Project title: TREATMENT OF OBESITY BY MINIMAL INVASIVE ELECTRIC STIMULATION OF THE ALIMENTARY TRACT

Company name : STIMPULSE LTD.

TECHNOLOGICAL FIELD
Health Care, Medical Devices,
Electrical Stimulaion, Obesity Treatment

KEY WORDS
Health Care, Medical Devices Obesity,
Bariatric, Minimal Invasion, Electrical Stimulation, Alimentary
Tract

PROJECT SUMMARY
STIMPULSE Ltd. is a medical device company that focuses on the
research and development of innovative, minimally invasive
medical devices for the treatment of obesity - the largest global
chronic disease in adults.
STIMPULSE Ltd. is committed to develop and commercialize novel
anti-obesity products that provide a meaningful contribution to
this leading healthcare problem facing the United States, and the
world today.
STIMPULSE Ltd. was conceived in order to create a safe, simple,
effective, and minimally invasive alternative to the surgical
treatment of obesity - an innovative approach to assist those
people who need help beyond traditional diets, and who wish to
avoid extensive, irreversible surgery.
STIMPULSE focuses on the development of systems based on
electrical stimulation of the alimentary tract which are applied
in non invasive methods.

THE MARKET
Market Size: It is estimated that more than 250 million people
suffer from obesity worldwide. Obesity has reached epidemic
proportions in the US, affecting approximately 40 million adults.
The Obesity Association estimates that 300,000 unnecessary deaths
a year in the US can be attributed to obesity. Obese persons are
at an increased risk for diabetes, coronary heart disease,
stroke, sleep apnea, stroke, gall bladder disease, several types
of cancer, and certain musculoskeletal disorders.

Market Trends: The Treatment of Obesity is dominated by the
surgical approach which is a robust market that has grown in the
US by 280% since 1999 and is projected to increase manifold over
the next twenty years. In 2007, there were over 200,000 bariatric
procedures performed in the US alone costing $5.5 billion
dollars.. Along side with the increased trend in obesity surgery,
it is anticipated that less invasive, and possibly non surgical
and less traumatic procedures will emerge with the capability to
significantly expand the patient target market towards
populations that wouldn't choose surgery as the preferred
solution to overweight condition.

ENTREPRENEURS
Mr. Jonathan Goldstein
Dr. Adrian Paz - MD
Mr. Michael Arad - CEO

PROJECT STATUS
The company operates within the Meytav Technological Incubator
since June, 2006.
STIMPULSE filed a Provisional US patent followed by a PCT
application.
The patent applications cover the company's developed implant,
its delivery system, and where applicable, the medical procedure
involved.

COOPERATION REQUIRED
Investment to accelerate product development.
Strategic partnership for market penetration.
------------------------------------------------
TEL. 972-4-6818801 FAX: 972-4-6818806 E-MAIL:
office@stimpulse.com WEB: www.stimpulse.com

Request for more information, about this project.

Note - you have to be registered in this server to request information. If you haven't done so yet, please:
Register in this server and your requests will be forwarded to the developer, who will contact you directly

List of projects that you already requested more information about